.-related side effects. its manufacturer, eli lilly, plans to submit a new drug application to the fda in the second half of 2018.
.
.
.
, et bureau |
.
.
published on: may 17, 2018 | last updated: may 17, 2018 5:42 pm pdt
.
.
richard lipton, md, director, montefiore headache center; edwin s. lowe professor and vice chairman of neurology, albert einstein college of medicine.
.
.